DGX vs RMTI · P/E 22, rev $5.94B vs rev $35.1M
Quest Diagnostics Incorporated (DGX) versus Rockwell Medical Inc (RMTI) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Rockwell Medical Inc (RMTI) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported RMTI revenue for 2026-06-30 was $35.1M. Net income was -$2.8M. RMTI currently screens at market cap $25.7M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. RMTI currently screens at market cap $25.7M.
Not investment advice. Open the DGX and RMTI stock pages for the full models.
Not investment advice.